# New Report: UK and Germany Medical Cannabis Markets Both Double in 2025

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/uk-germany-medical-cannabis-markets-double-2025/
> **Published:** 2026-03-26T02:07:55-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:17:41-04:00
> **Clinical Summary:** Explore how UK Germany medical cannabis markets doubled in 2025, signaling growth in patient access and clinical acceptance.

---

✦ New
CED Clinical Relevance  #76Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
⚒ Cannabis News  |  CED Clinic
International MedicineMarket AccessPrescription PatternsHealthcare SystemsClinical Data

Why This Matters

Rapid market expansion in established healthcare systems like the UK and Germany signals growing clinical acceptance and patient access to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). This trend provides valuable real-world data on prescription patterns and patient outcomes in regulated medical frameworks that can inform evidence-based practice globally.

Clinical Summary
Both the UK and German [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) markets experienced significant growth in 2025, with market values doubling year-over-year. This expansion reflects increased physician prescribing, improved patient access through healthcare systems, and growing clinical familiarity with cannabis therapeutics. The growth occurs within established regulatory frameworks that require medical oversight and documentation, providing structured data on clinical applications and patient responses.

Dr. Caplan’s Take

“Market growth in rigorous healthcare systems like these creates the clinical data infrastructure we desperately need – real prescribing patterns, patient outcomes, and safety profiles at scale. This is how [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) matures from anecdote to evidence.”

Clinical Perspective
🧠 Clinicians should monitor emerging data from these expanded programs for insights into dosing protocols, therapeutic applications, and safety profiles. The structured nature of these medical systems provides more reliable clinical data than less regulated markets, potentially informing best practices for [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and prescription decision-making.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20New%20Report%3A%20UK%20and%20Germany%20Medical%20Cannabis%20Markets%20Both%20Double%20in%202025%20%40drcaplan&url=https%3A//businessofcannabis.com/new-report-uk-and-germany-medical-cannabis-markets-both-double-in-2025/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//businessofcannabis.com/new-report-uk-and-germany-medical-cannabis-markets-both-double-in-2025/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20New%20Report%3A%20UK%20and%20Germany%20Medical%20Cannabis%20Markets%20Both%20Double%20in%202025%20--%20via%20%40drcaplan.bsky.social%20https%3A//businessofcannabis.com/new-report-uk-and-germany-medical-cannabis-markets-both-double-in-2025/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://businessofcannabis.com/new-report-uk-and-germany-medical-cannabis-markets-both-double-in-2025/](https://businessofcannabis.com/new-report-uk-and-germany-medical-cannabis-markets-both-double-in-2025/)

{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “New Report: UK and Germany [Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) Markets Both Double in 2025”, “url”: “https://businessofcannabis.com/new-report-uk-and-germany-medical-cannabis-markets-both-double-in-2025/”, “datePublished”: “2026-03-26T03:52:29Z”, “about”: “new report uk germany medical cannabis”}

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[UK medical cannabis for chronic pain: what 792 current patients reported – Reddit](https://cedclinic.com/uk-medical-cannabis-chronic-pain-outcomes-patient-insights/)

Insights from UK patients using medical cannabis for [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), highlighting real-world experiences and outcomes.

[Read Patient Reports](https://cedclinic.com/uk-medical-cannabis-chronic-pain-outcomes-patient-insights/)

[German Medical Cannabis Patients Report Reduced Prescription Drug Use, Survey Finds](https://cedclinic.com/german-medical-cannabis-patients-report-reduced-prescription-use/)

Survey results showing how German medical cannabis patients have reduced reliance on prescription medications.

[View Survey Findings](https://cedclinic.com/german-medical-cannabis-patients-report-reduced-prescription-use/)

[Cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) is more than a scientific pursuit—it's a pathway to better health, informed …

Explore how [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) contributes to improved health outcomes and evidence-based clinical practice.

Explore Research

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).